BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chapa-gonzález C, López K, Lomelí KM, Roacho-pérez JA, Stevens JC. A Review on the Efficacy and Safety of Nab-Paclitaxel with Gemcitabine in Combination with Other Therapeutic Agents as New Treatment Strategies in Pancreatic Cancer. Life 2022;12:327. [DOI: 10.3390/life12030327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ou Y, Wang R, Chu GC, Elmadbouh OHM, Lim A, Chung LW, Edderkaoui M, Zhang Y, Pandol SJ. Novel DZ-SIM Conjugate Targets Cancer Mitochondria and Prolongs Survival in Pancreatic Ductal Adenocarcinoma. Adv Ther (Weinh) 2022;5:2200021. [PMID: 36590644 DOI: 10.1002/adtp.202200021] [Reference Citation Analysis]
2 Capula M, Perán M, Xu G, Donati V, Yee D, Gregori A, Assaraf YG, Giovannetti E, Deng D. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance. Drug Resist Updat 2022;64:100864. [PMID: 36115181 DOI: 10.1016/j.drup.2022.100864] [Reference Citation Analysis]